4.7 Article

Identification of a unique epigenetic profile in women with diminished ovarian reserve

Journal

FERTILITY AND STERILITY
Volume 115, Issue 3, Pages 732-741

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2020.09.009

Keywords

DNA methylation; epigenetics; granulosa cells; ovarian reserve; reproduction

Funding

  1. Repro Union Program
  2. European Union, Interreg VOKS
  3. Capital region of Denmark
  4. Region Zealand
  5. Region Skane
  6. Ferring Pharmaceutical Company
  7. Department of Gynaecology-Obstetrics at Herlev-Gentofte Hospital, Denmark
  8. Danish National Research Foundation (DNRF)
  9. Center for Chromosome Stability at the University of Copenhagen [DNRF115]
  10. Novo Nordisk Foundation Young Investigator Award [NNF15OC0016662]
  11. UK Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0425]
  12. Medical Research Council [MR/S000437/1]
  13. BBSRC [BBS/E/B/000C0425] Funding Source: UKRI
  14. MRC [MC_UU_12015/2, MC_UU_00006/2, MR/S000437/1] Funding Source: UKRI

Ask authors/readers for more resources

Epigenetic profiles of mural granulosa cells (MGC) from women with diminished ovarian reserve (DOR) show differential methylation variability compared to those with normal ovarian reserve, with enrichment in regions marked with the repressive histone modification H3K27me3 and involvement of genes related to folliculogenesis. Leukocytes did not show significant differences in epigenetic profiles based on ovarian reserve status. A higher number of epimutations in MGC from women with DOR suggest premature aging in ovarian follicle cells.
Objective: To investigate whether epigenetic profiles of mural granulosa cells (MGC) and leukocytes from women with diminished ovarian reserve (DOR) differ from those of women with normal or high ovarian reserve. Design: Prospectively collected material from a multicenter cohort of women undergoing fertility treatment. Setting: Private and university-based facilities for clinical services and research. Patient(s): One hundred and nineteen women of various ages and ovarian reserve status (antimullerian hormone level) who provided blood samples and MGC. Intervention(s): None. Main Outcome Measure(s): Measures of epigenetic aging rates from whole-genome methylation array data: DNA methylation variability, age acceleration, DNA methylation telomere length estimator (DNAmTL), and accumulation of epimutations. Result(s): Comparison of DOR or high ovarian reserve samples to controls (normal ovarian reserve) showed differential methylation variability between DOR and normal samples at 4,199 CpGs in MGC, and 447 between high and normal (false-discovery rate < 0.05). Variable sites in MGC from DOR were enriched in regions marked with the repressive histone modification H3K27me3, and also included genes involved in folliculogenesis, such as insulin growth factor 2 (IGF2) and antim_ullerian hormone (AMH). Regardless of ovarian reserve, very few signals were detected in leukocytes, and no overlaps with those in MGC were found. Furthermore, we found a higher number of epimutations in MGC from women with DOR (Kruskal-Wallis test, difference in mean = 3,485). Conclusion(s): The somatic cells of human ovarian follicles have a distinctive epigenetic profile in women with DOR. A high frequency of epimutations suggests premature aging. Ovarian reserve status was not reflected in the leukocyte epigenetic profile. (C) 2020 by American Society for Reproductive Medicine.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available